<- Go Home
Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Market Cap
$76.7M
Volume
2.8K
Cash and Equivalents
$16.4M
EBITDA
-$35.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$28.68
52 Week Low
$4.11
Dividend
N/A
Price / Book Value
1.87
Price / Earnings
-0.65
Price / Tangible Book Value
1.87
Enterprise Value
$60.4M
Enterprise Value / EBITDA
-1.70
Operating Income
-$35.6M
Return on Equity
137.40%
Return on Assets
-67.66
Cash and Short Term Investments
$16.4M
Debt
N/A
Equity
$9.4M
Revenue
N/A
Unlevered FCF
-$18.4M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium